Home From Drew Altman

From Drew Altman

Drew Altman is president and chief executive officer of KFF, a position he has held for more than 30 years since founding the modern-day KFF organization in the 1990s. He is a leading expert on national health policy issues and an innovator in health journalism and the nonprofit field.

View full bio | Read Dr. Altman's Beyond the Data columns

Photo of Drew Altman

President’s Message

“KFF is an independent source of health policy research, polling, and journalism. We have four major program areas: KFF Policy; KFF Polling; KFF Health News (formerly Kaiser Health News); and KFF Social Impact Media, which conducts specialized public health information campaigns. Learn more about the organization. 

What’s unique about KFF, however, can’t be found in any description of our programs because we’re more than a sum of our parts. KFF is a one-of-a-kind information organization. Not a policy research organization. Not a polling organization. And not a news organization. But rather, a unique combination of all three. That’s the vision behind KFF, and it's this combination that allows us to leverage our combined expertise and assets to play our national role on health policy.”

Read more

Beyond the Data

In his “Beyond the Data” columns, Dr. Altman discusses what the data, polls, and journalism produced by KFF mean for policy and for people.

Drew Altman, KFF President and CEP is quoted on this card saying, "People are bewildered by a supercharged and polarized debate about vaccines and no longer know where to turn for scientific information they can rely on ... The vaccines are not the culprit—we and the state of our politics and the distrust in science and our scientific institutions they breed are."

The Problem Isn’t Trust in Vaccines, It’s That People Don’t Know Who to Trust

In a new “Beyond the Data” column, Dr. Altman analyzes years of KFF polling on vaccines in light of the current controversies about them. The real problem, he says, is not lack of public confidence in the safety of vaccines — few say they are unsafe — it’s that polarization and misinformation have eroded confidence in what’s true or not, and in scientific institutions people used to rely on for the facts.

View All Beyond the Data Columns

View the Latest: From Drew Altman

Filter

List Grid

131 - 140 of 324 Results

  • The Politics of ACA Rate Hikes Will Be 2016 in Reverse

    From Drew Altman

    Democrats are expected to turn the tables and attack Republicans for rising premiums and sabotaging the Affordable Care Act. In his Axios column, Drew Altman discusses a balancing act they face which has not received attention: score political points, but run the risk of a new debate scaring the broader public and undermining the ACA by focusing on its continuing problems.

  • Red-State Changes Could Strengthen ACA, Medicaid

    From Drew Altman

    In an Axios column, Drew Altman discusses how, ironically, efforts by red states to move their ACA marketplaces and their Medicaid programs in  more conservative directions could end up strengthening the ACA and Medicaid politically over the longer term.

  • Don’t Overhype the New Health Care Venture

    From Drew Altman

    In an Axios column, Drew Altman dissects the many dimensions of the health cost problem and discusses why the Bezos-Buffett-Dimon initiative is unlikely to have much impact on the larger health cost problems the public and policymakers care about most.

  • Why Medicaid Work Requirements Aren’t the Same as Welfare Reform

    From Drew Altman

    Drawing on his experience in state welfare reform, Drew Altman, in his Axios column, discusses how new state Medicaid work requirements differ fundamentally from welfare reform, which was built on the idea of a “reciprocal obligation” between both beneficiaries and government to do more.  

  • Don’t Read Too Much Into Health Care’s High Poll Rankings

    From Drew Altman

    This Drew Altman column for Axios discusses how health care being ranked as a high priority, and as the number one issue in a recent national poll, doesn’t mean it will be a major factor in this November’s elections.

  • Tax Cuts Could Make It Harder to Change Medicare, Medicaid

    From Drew Altman

    In this Axios column, Drew Altman discusses how cutting Medicare and Medicaid has always been a challenge, but if the public comes to view “entitlement reform” as a means to pay for tax cuts, the GOP will have an even stiffer challenge, including with their base.

  • ACA Mandate Repeal May Be Less Popular Than GOP Thinks

    From Drew Altman

    In this Axios column, Drew Altman discusses how public opinion seems to flip on eliminating the individual mandate as part of the tax legislation, from for it to against, when the public considers the consequences.

  • The Biggest Health Issue We Aren’t Debating

    From Drew Altman

    In an Axios column, Drew Altman raises a health care issue that isn’t being debated, a large share of the public don’t have the assets to cover the cost sharing in their health plan if they get sick.

  • How the Elections Could Put the Brakes on Anti-ACA Plans

    From Drew Altman

    In this Axios column, Drew Altman examines the role of health care in Virginia's elections and the referendum on Medicaid expansion in Maine. His assessment: the elections and the referendum will have a bigger impact on upcoming policy debates about cutting Medicaid to pay for tax cuts, and state interest in Medicaid expansion, than on upcoming elections.